REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Na Dozynkowej Koziol sp. j. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | All Other Support Services
Full name: Apteka Na Dozynkowej Koziol sp. j. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteka Na Dozynkowej Koziol sp. j. is a company in Poland, with a head office in Lublin. It operates in the Department Stores industry. It was first established on March 01, 2021. There was a net sales revenue increase of 8.97% reported in Apteka Na Dozynkowej Koziol sp. j.’s latest financial highlights for 2023. A growth of 18.52% was recorded in its total assets. The net profit margin of Apteka Na Dozynkowej Koziol sp. j. increased by 2.75% in 2023.

Headquarters
Ul. Dozynkowa 1
Lublin; Lubelskie; Postal Code: 20-152

Contact Details: Purchase the Apteka Na Dozynkowej Koziol sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Na Dozynkowej Koziol sp. j. report to view the information.
Incorporation Date:
March 01, 2021
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka Na Dozynkowej Koziol sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.97%
Total operating revenue
8.49%
Operating profit (EBIT)
38.6%
Net Profit (Loss) for the Period
44.96%
Total assets
18.52%
Total equity
83.93%
Operating Profit Margin (ROS)
2.39%
Net Profit Margin
2.75%
Return on Equity (ROE)
-12.09%
Quick Ratio
0.96%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?